Repligen (RGEN) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.98% |
| Dec 31, 2025 | -4.63% |
| Sep 30, 2025 | 6.24% |
| Jun 30, 2025 | 4.81% |
| Mar 31, 2025 | 5.66% |
| Dec 31, 2024 | 7.47% |
| Sep 30, 2024 | 8.83% |
| Jun 30, 2024 | 31.11% |
| Mar 31, 2024 | 31.82% |
| Dec 31, 2023 | 31.12% |
| Sep 30, 2023 | 27.08% |
| Jun 30, 2023 | 28.01% |
| Mar 31, 2023 | 24.33% |
| Dec 31, 2022 | 24.68% |
| Sep 30, 2022 | 29.13% |
| Jun 30, 2022 | 33.21% |
| Mar 31, 2022 | 35.15% |
| Dec 31, 2021 | 37.64% |
| Sep 30, 2021 | 31.55% |
| Jun 30, 2021 | 33.59% |
| Mar 31, 2021 | 67.96% |
| Dec 31, 2020 | 67.69% |
| Sep 30, 2020 | 63.00% |
| Jun 30, 2020 | 69.53% |
| Mar 31, 2020 | 76.16% |
| Dec 31, 2019 | 71.74% |
| Sep 30, 2019 | 70.24% |
| Jun 30, 2019 | 43.98% |
| Mar 31, 2019 | 31.86% |
| Dec 31, 2018 | 37.23% |
| Sep 30, 2018 | 35.13% |
| Jun 30, 2018 | 36.30% |
| Mar 31, 2018 | 43.50% |
| Dec 31, 2017 | 42.85% |
| Sep 30, 2017 | 54.07% |
| Jun 30, 2017 | 55.03% |
| Mar 31, 2017 | 58.92% |
| Dec 31, 2016 | 61.38% |
| Sep 30, 2016 | 71.91% |
| Jun 30, 2016 | 87.41% |
| Mar 31, 2016 | 30.23% |
| Dec 31, 2015 | 40.74% |
| Sep 30, 2015 | 25.96% |
| Jun 30, 2015 | 36.86% |